Page 53 of 54 · 1,592 total

patent pending · Feb 22, 2024

Panasonic Holdings Corporation v.OROPE Germany GmbH, Guangdong OPPO Mobile Telecommunications Corp. Ltd.

Mannheim (DE) Local Division · ORD_7587/2024

In a procedural ruling, the Mannheim Local Division addressed the complex interplay between infringement and invalidity claims in UPC case UPC_CFI_216/2023. The court decided to consolidate the proceedings, meaning that Panasonic's infringement claim will be heard alongside OROPE and OPPO's counterclaim for patent invalidity and FRAND licensing. This consolidation aims to ensure a unified legal interpretation across all issues, streamlining the litigation process.

patent pending · Feb 22, 2024

Panasonic Holdings Corporation v.Xiaomi Technology Germany GmbH, Xiaomi Technology France S.A.S., Xiaomi Technology Italy S.R.L, Xiaomi Technology Netherlands B.V., Odiporo GmbH, Shamrock Mobile GmbH, Beijing Xiaomi Mobile Software Co. Ltd., Xiaomi Communications Co., Ltd., Xiaomi H.K. Limited, Xiaomi Inc.

Mannheim (DE) Local Division · ORD_7585/2024

In a procedural ruling, the Mannheim Local Division of the UPC decided to consolidate an infringement lawsuit brought by Panasonic Holdings Corporation against various Xiaomi entities with their counterclaim for patent invalidity and FRAND licensing. The court emphasized that combining these proceedings would ensure efficiency and allow for a unified legal interpretation regarding both validity and infringement. This order sets the stage for the substantive examination of the dispute.

patent denied · Feb 22, 2024

Netgear Inc. v.Huawei Technologies Co. Ltd

Luxembourg (LU) · App_7580/2024

This UPC decision addresses a procedural motion filed by Netgear seeking to accelerate the appellate proceedings against Huawei. Netgear argued that strict deadlines would prevent them from presenting their defense in time, given the urgency of the underlying case. However, the Board of Appeal rejected this request, emphasizing the importance of maintaining an orderly and fair procedure for all parties involved. The ruling serves as a reminder that procedural fairness often outweighs claims of urgent necessity in UPC litigation.

patent pending · Feb 22, 2024

Panasonic Holdings Corporation v.OROPE Germany GmbH, Guangdong OPPO Mobile Telecommunications Corp. Ltd.

Mannheim (DE) Local Division · ORD_7452/2024

In this procedural order, the Lokalkammer Mannheim addressed the structure of a complex UPC case involving infringement and revocation claims against OPPO and OROPE. The court ruled that combining the infringement lawsuit with the counterclaim for non-validity (including FRAND licensing) was procedurally efficient and substantively advantageous. This decision sets an early precedent for managing multi-faceted disputes within the UPC framework.

patent pending · Feb 22, 2024

Panasonic Holdings Corporation v.Xiaomi Technology Germany GmbH, Xiaomi H.K. Limited, Xiaomi Communications Co., Ltd., Xiaomi Technology France S.A.S, Xiaomi Inc., Odiporo GmbH, Beijing Xiaomi Mobile Software Co. Ltd., Xiaomi Technology Netherlands B.V., Shamrock Mobile GmbH, Xiaomi Technology Italy S.R.L

Mannheim (DE) Local Division · ORD_7586/2024

In a case involving Panasonic Holdings Corporation against various Xiaomi entities, the Local Court of Mannheim issued an order regarding procedural matters. The court decided to consolidate the infringement claim and the counterclaim for revocation (including FRAND licensing) into a single proceeding. This strategic decision aims to enhance judicial efficiency by ensuring a unified legal interpretation across both claims.

patent denied · Feb 22, 2024

Netgear International Limited, NETGEAR Deutschland GmbH, Netgear Inc. v.Huawei Technologies Co. Ltd

Luxembourg (LU) · App_7573/2024

This UPC decision concerns an application for acceleration of appeal proceedings filed by Netgear against a ruling that allowed the expansion of claims in the main infringement case. The Board of Appeal ultimately denied the request, emphasizing procedural fairness and proportionality. The court determined that granting the accelerated timeline would prejudice Huawei's right to prepare a proper defense response within the established legal framework.

patent pending · Feb 22, 2024

Panasonic Holdings Corporation v.OROPE Germany GmbH, Guangdong OPPO Mobile Telecommunications Corp. Ltd.

Mannheim (DE) Local Division · ORD_7584/2024

In a procedural ruling, the Mannheim Local Division addressed the joint handling of claims in the case involving Panasonic Holdings Corporation and OPPO Mobile Telecommunications Corp. Ltd. The court decided to consolidate the infringement claim with the counterclaim for patent revocation and FRAND licensing. This decision emphasizes judicial efficiency by ensuring that both the validity and infringement aspects are judged under a single, unified interpretation by the same panel.

patent pending · Feb 22, 2024

Panasonic Holdings Corporation v.Xiaomi Technology Germany GmbH, Xiaomi Technology France S.A.S, Xiaomi Technology Italy S.R.L, Xiaomi Technology Netherlands B.V., Odiporo GmbH, Shamrock Mobile GmbH, Beijing Xiaomi Mobile Software Co. Ltd., and others (collectively 'Xiaomi')

Mannheim (DE) Local Division · ORD_7453/2024

In a procedural ruling, the Local Division of Mannheim addressed the complex interplay between infringement claims and counterclaims for patent invalidity (revocation) and FRAND licensing. The court determined that hearing these matters jointly was procedurally efficient and substantively advantageous, ensuring a unified legal interpretation across all issues. This decision is significant as it reinforces the UPC's ability to manage multi-faceted litigation strategically, optimizing judicial resources while maintaining consistency in legal findings.

patent denied · Feb 20, 2024

Tandem Diabetes Care, Inc. v.Roche Diabetes Care GmbH

Paris (FR) Central Division - Seat · App_8392/2024

In this procedural order, the UPC Central Division addressed a request by Tandem Diabetes Care to extend its deadline for filing a defense in an action for declaration of non-infringement against Roche. The Court ultimately denied the extension, emphasizing that while flexibility is required under UPC rules, extensions must be based on objective difficulties preventing timely submission, not merely on strategic concerns related to preliminary objections or parallel proceedings. This decision reinforces the strict application of procedural deadlines unless exceptional circumstances are proven.

patent denied · Feb 20, 2024

Tandem Diabetes Care, Inc. v.Roche Diabetes Care GmbH

Paris (FR) Central Division - Seat · UPC_CFI_454/2023

In this procedural order, the UPC Central Division addressed a request by Roche Diabetes Care GmbH to extend its deadline for filing a defense in a revocation action against Tandem Diabetes Care. Roche argued that the pending preliminary objection made timely submissions potentially useless and costly. The Court ultimately denied the extension, emphasizing that while flexibility is allowed under Rule 9 RoP, extensions must be justified by an objective difficulty in preparing a proper defense, not merely by procedural uncertainty.

patent pending · Feb 15, 2024

Meril GmbH v.Edwards Lifesciences Corporation

Luxembourg (LU) · UPC_CoA_2/2024

This UPC appellate decision concerns a dispute over court fees in an appeal filed by Meril GmbH and Meril Life Sciences Pvt Ltd. against Edwards Lifesciences Corporation. The original case involved infringement allegations related to heart valve prostheses. The current ruling focuses purely on procedural matters, specifically determining the correct fee for the appeal based on the nature of the underlying decision (an order concerning provisional measures). The court ultimately ordered the appellants to pay a remaining balance of €9,500.

patent pending · Feb 15, 2024

Plant-e Knowledge B.V. v.Arkyne Technologies S.L.

The Hague (NL) Local Division · UPC_CFI_239/2023

In a procedural order, the UPC Local Division The Hague decided to proceed with both an infringement action and a counterclaim for revocation concerning patent EP2137782. This decision was made to ensure procedural expediency and allow for a uniform interpretation of the patent by the same panel. This ruling highlights the court's preference for integrated proceedings when parties agree, avoiding potential delays associated with bifurcating cases.

patent pending · Feb 14, 2024

Panasonic Holdings Corporation v.Guangdong OPPO Mobile Telecommunications Corp. Ltd., OROPE Germany GmbH

Mannheim (DE) Local Division · UPC_CFI_210/2023

This UPC CFI order established a detailed confidentiality regime for the ongoing proceedings between Panasonic and OPPO. The court recognized the need to protect sensitive business information, particularly licence agreements related to SEP patents, while still allowing parties to submit relevant documents. This ruling provides clear procedural guidance on how unredacted confidential material can be shared with opposing counsel under strict judicial oversight.

patent pending · Feb 12, 2024

DexCom, Inc. v.Abbott Laboratories and associated entities (including Abbott Diabetes Care Inc., Newyu,Inc., etc.)

Paris (FR) Local Division · ORD_7657/2024

This procedural order in the DexCom v. Abbott case addressed the complexities of managing deadlines when multiple defendants are involved. The UPC granted an extension and aligned the Statement of Defence filing date for all 14 entities based on a mutual agreement between the parties. This decision highlights the court's pragmatic approach to ensuring fair procedure while accommodating the logistical challenges presented by large, multi-jurisdictional litigation.

patent partially granted · Feb 12, 2024

ICPillar LLC v.Arm Poland Sp. z.o.o, ARM Limited, Simulity Labs Limited, Hyperglance limited, SVF Holdco, Apical Limited (and other defendants)

Paris (FR) Local Division · App_5858/2024

This procedural order addressed the service of a Statement of Claim in an infringement action involving ICPillar LLC and various ARM group entities. The Court granted authorization for alternative service methods specifically for the Polish defendant, Arm Poland Sp. z.o.o., due to delivery issues. However, the request for alternative service concerning UK defendants was dismissed because the Hague Service Convention process was still considered reasonable and in progress.

patent pending · Feb 12, 2024

Abbott Diabetes Care Inc. v.Dexcom Inc., Dexcom France SAS, Dexcom International Limited

Paris (FR) Local Division · ORD_7664/2024

This procedural order in the Abbott v. Dexcom case addresses complexities arising from service issues across multiple defendants. The Judge-Rapporteur, utilizing UPC Rules of Procedure (RoP), granted an extension and aligned the deadline for filing the Statement of Defence for all three Dexcom entities. This decision highlights the court's pragmatic approach to ensuring fair procedural timelines in multi-defendant infringement actions.

patent pending · Feb 12, 2024

Heraeus Electronics GmbH & Co. KG v.Vibrantz GmbH

Munich (DE) Local Division · UPC_CFI_114/2024

This procedural order in the UPC case between Heraeus Electronics and Vibrantz addresses multiple complex applications concerning claim expansion, particularly regarding patent infringement claims in Romania. The Court proposed a unified approach to manage these expansions efficiently, aiming to prevent divergent decisions across different jurisdictions (Germany, France, Italy). By agreeing to this framework, both parties can proceed with their respective claims while adhering to the UPC's principles of procedural economy.

patent denied · Feb 9, 2024

ITCiCo Spain S.L. v.Bayerische Motoren Werke Aktiengesellschaft

Paris (FR) Central Division - Seat · UPC_CFI_412/2023

In a procedural matter concerning a revocation action, the UPC Central Division denied an application by ITCiCo Spain S.L. seeking an extension of time to file its statement of defence against Bayerische Motoren Werke AG. The court strictly applied the principles governing discretionary extensions, requiring objective impossibility rather than subjective difficulties like illness or technical access issues. This decision reinforces the strict nature of procedural deadlines within the UPC framework.

patent pending · Feb 9, 2024

Abbott Diabetes Care Inc. v.Dexcom Inc., Dexcom International Limited

The Hague (NL) Local Division · UPC_CFI_424/2023

This procedural order in Abbott Diabetes Care Inc. v. Dexcom Inc. confirms the ongoing infringement action concerning EP4070727, a patent related to diabetes care technology. The court accepted the parties' agreement to synchronize the filing dates for the Statements of Defence (SoD) for both defendants. This decision highlights how UPC proceedings prioritize procedural efficiency and party cooperation in managing complex litigation timelines.

patent pending · Feb 9, 2024

Huawei Technologies Co. Ltd v.NETGEAR Deutschland GmbH, Netgear Inc., Netgear International Limited

Munich (DE) Local Division · UPC_CFI_9/2023

This UPC decision addresses the procedural language of a patent infringement case involving Huawei and Netgear. Although the official procedure language is German, the court utilized its discretionary powers to permit the oral hearings and interim proceedings to be conducted in English. This ruling emphasizes the balance between strict procedural rules and the practical need for efficiency and cost-saving in complex international litigation.

patent pending · Jan 31, 2024

NanoString Technologies Europe Limited v.President and Fellows of Harvard College

Munich (DE) Central Division - Section · ORD_598206/2023

This UPC decision was a procedural order in the revocation action concerning EP2794928. The court addressed several key issues during an interim conference, including admitting crucial prior art (D46) and setting the financial parameters of the dispute. By confirming the hearing date and establishing the value of the proceedings at EUR 7.5 million, the Court moved the case closer to a substantive judgment.

patent pending · Jan 31, 2024

NanoString Technologies Europe Limited v.President and Fellows of Harvard College

Munich (DE) Central Division - Section · ORD_598209/2023

This UPC decision is a procedural order in a revocation action brought by NanoString Technologies against Harvard College concerning EP2794928. The court reinforced the strict 'front-loaded' nature of UPC proceedings, setting clear boundaries for amendments and late submissions. Key decisions included admitting new prior art (D46) into the case and formally establishing the financial value of the dispute at EUR 7.5 million for cost assessment. This order moves the case closer to trial while maintaining strict procedural discipline.

patent denied · Jan 18, 2024

Edwards Lifesciences Corporation v.Meril GmbH; Meril Life Sciences Pvt Ltd.

Luxembourg (LU) · UPC_CoA_4/2024

This UPC Court of Appeal decision addresses an application for suspensive effect concerning a cost order issued by the Court of First Instance (CFI). The CFI had ordered Meril GmbH and Meril Life Sciences to bear significant costs after the main provisional measures action became moot due to a cease-and-desist undertaking. The Appellants appealed this cost ruling, arguing that further procedural steps would incur unnecessary expenses. However, the UPC Court of Appeal rejected the application for suspensive effect, emphasizing the procedural priority given to timely cost decisions under the Rules of Procedure.

patent granted · Jan 11, 2024

Netgear Inc. v.Huawei Technologies Co. Ltd

Luxembourg (LU) · UPC_CoA_486/2023

This UPC Court of Appeal decision addresses a complex procedural matter concerning the admissibility of discretionary review against an order issued by a Judge Rapporteur. Netgear sought to challenge the JR's refusal to refer a preliminary objection decision to the panel for review. The court ruled that the request was admissible, allowing the appeal to proceed against the JR's ruling on admissibility itself. This case clarifies the procedural pathways available under the UPC Rules when challenging initial case management decisions.

patent pending · Dec 22, 2023

Abbott Diabetes Care Inc. v.Dexcom Inc., Dexcom International Limited

The Hague (NL) Local Division · UPC_CFI_424/2023

This UPC CFI decision addressed a procedural hurdle in the infringement action brought by Abbott Diabetes Care Inc. against Dexcom Inc. and its international subsidiary. The court accepted evidence that proper service had been effected on the defendant using an Irish process server, thereby resolving a key jurisdictional issue. This ruling allows the main infringement proceedings to move forward, setting a clear timeline for filing the Statement of Claim.

patent denied · Dec 20, 2023

Guangdong OPPO Mobile Telecommunications Corp. Ltd. v.Panasonic Holdings Corporation

Luxembourg (LU) · UPC_CoA_478/2023

In a procedural matter concerning the expedition of an appeal, the UPC Court of Appeal denied the request made by Guangdong OPPO Mobile Telecommunications Corp. Ltd. The core issue was whether to shorten the time period for the Respondent's Statement of response. The court emphasized principles of proportionality and due process, concluding that granting the expedited timeline would prejudice the Respondent's right to adequate preparation time. This decision highlights the Court's commitment to procedural fairness over merely accommodating a party's urgency.

patent denied · Dec 19, 2023

Guangdong OPPO Mobile Telecommunications Corp. Ltd. v.Panasonic Holdings Corporation

Luxembourg (LU) · UPC_CoA_476/2023

In a procedural matter concerning the expedition of an appeal, the UPC Court of Appeal rejected the request made by Guangdong OPPO Mobile Telecommunications Corp. Ltd. The core issue was whether to shorten the time period for Panasonic Holdings Corporation's Statement of response. The court ruled that due process and proportionality required giving the Respondent adequate time to prepare its defense, even if it meant delaying the proceedings.

patent denied · Dec 18, 2023

Guangdong OPPO Mobile Telecommunications Corp. Ltd. v.Panasonic Holdings Corporation

Luxembourg (LU) · UPC_CoA_472/2023

In a procedural ruling, the UPC Court of Appeal rejected an application by OPPO and OROPE to shorten the time period for the Respondent, Panasonic Holdings Corporation, to file its Statement of response. The court emphasized that while expediency is desired, procedural fairness and proportionality must be maintained. This decision highlights the court's commitment to due process, even when it means delaying a party's preferred timeline.

patent pending · Oct 22, 2023

10x Genomics, Inc. v.Vizgen, Inc.

Hamburg (DE) Local Division · App_49415/2024

In this UPC case concerning patent infringement, the court issued a complex order regarding document disclosure stemming from parallel US litigation. The respondent sought to introduce evidence related to non-technical issues (such as competitive practices) into the European proceedings. The court granted the submission of specific documents but imposed stringent confidentiality requirements ('Outside Attorneys' Eyes Only'), balancing the need for evidence with protecting trade secrets.

patent partially granted · Oct 13, 2023

Sanofi-Aventis Deutschland GmbH; Sanofi-Aventis Groupe S.A.; Sanofi Winthrop Industrie S.A.; Regeneron Pharmaceuticals Inc. v.Amgen, Inc.

Luxembourg (LU) · UPC_CoA_320/2023

This UPC Court of Appeal decision addresses a critical procedural issue regarding the service of claims when supporting annexes are submitted later than the initial Statement of Claim. The court affirmed that a claim can be validly served even if it refers to future annexes, provided the core statement is complete enough for the defendant to assert their rights. Crucially, the ruling established that failure by the claimant to comply with simultaneous submission rules (Rule 13.2 RoP) automatically entitles the defendant to an extension of procedural deadlines equal to the delay period.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →